Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: Implication of PKC-potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 2, 2011, Pages 366-375

  Morin, Caroline ^a   Fortin, Samuel ^b   Cantin, André M ^a   Rousseau, Éric ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b Marine Biotechnology Research Centre   (Canada)

Author keywords

Airway hyperresponsiveness; Asthma; CPI 17; DHA; Inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CRBM 0244; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSIN LIGHT CHAIN PHOSPHATASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS HYPERREACTIVITY; FEMALE; GUINEA PIG; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG BIOPSY; MALE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; ASTHMA; BLOTTING, WESTERN; BRONCHI; BRONCHIAL HYPERREACTIVITY; CALCIUM; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACIDS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GUINEA PIGS; HUMANS; LUNG NEOPLASMS; MALE; MONOGLYCERIDES; MUSCLE, SMOOTH; NF-KAPPA B; PHOSPHOPROTEIN PHOSPHATASES; PNEUMONIA; PROTEIN KINASE C; TUMOR NECROSIS FACTOR-ALPHA;

CAVIA;

EID: 80051634467     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0156OC     Document Type: Article

References (44)

1. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol 2008;8:218-230. (Pubitemid 351323290)
2. Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med 2009;9:24.
3. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745. (Pubitemid 30329053)
4. Mitzner W, Brown RH. Potential mechanism of hyperresponsive airways. Am J Respir Crit Care Med 2000;161:1619-1623.
5. Janssen LJ. Calcium handling in airway smooth muscle: mechanisms and therapeutic implications. Can Respir J 1998;5:491-498. (Pubitemid 29052085)
6. Tliba O, Deshpande D, Chen H, Van Besien C, Kannan M, Panettieri RA Jr, Amrani Y. IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol 2003; 140:1159-1162. (Pubitemid 38117418)
7. Siddiqui S, Hollins F, Saha S, Brightling CE. Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur Respir J 2007;30:1043-1056. (Pubitemid 351194749)
8. Nathan C. Points of control in inflammation. Nature 2002;420:846-852. (Pubitemid 36019637)
9. Sijben JW, Calder PC. Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc 2007;66: 237-259. (Pubitemid 46684976)
10. Needleman P, Raz A, Minkes MS, Ferrendelli JA, Sprecher H. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties. Proc Natl Acad Sci USA 1979;76:944-948. (Pubitemid 9130979)
11. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 1984;74: 1922-1933. (Pubitemid 15197332)
12. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 2000;192:1197-1204.
13. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 2002;196:1025-1037. (Pubitemid 35231761)
14. Jia Q, Lupton JR, Smith R, Weeks BR, Callaway E, Davidson LA, Kim W, Fan YY, Yang P, Newman RA, et al. Reduced colitis-associated colon cancer in Fat-1 (n-3 fatty acid desaturase) transgenic mice. Cancer Res 2008;68:3985-3991.
15. Morin C, Sirois M, Echave V, Rousseau E. CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi. Am J Respir Cell Mol Biol 2008;39:638-643.
16. Morin C, Sirois M, Echave V, Albadine R, Rousseau E. 17,18-EpETE targets PPARγ and p38MAPK to mediate its anti-inflammatory effect in lung: role of sEH. Am J Respir Cell Mol Biol 2010;43:564-575.
17. Fortin S, inventor. Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof. Canadian patent WO2008/098375. August 21, 2008.
18. + channel activation and CPI-17 dephosphorylation in human bronchi. Am J Respir Cell Mol Biol 2007;36:633-641.
19. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659-661. (Pubitemid 351348146)
20. Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola AM. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma. Am J Respir Crit Care Med 2003;168:1190-1198. (Pubitemid 37424040)
21. Murdoch JR, Lloyd CM. Chronic inflammation and asthma. Mutat Res 2010;690:24-39.
22. Brightling C, Berry M, Amrani Y. Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol 2008;121:5-10, 11-12.
23. Gosset P, Tsicopoulos A, Wallaert B, Vannimenus C, Joseph M, Tonnel AB, Capron A. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991;88:561-571.
24. Shah A, Church MK, Holgate ST. Tumour necrosis factor alpha: a potential mediator of asthma. Clin Exp Allergy 1995;25:1038-1044.
25. Babcock TA, Helton WS, Anwar KN, Zhao YY, Espat NJ. Synergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pretreatment on macrophage proinflammatory cytokine production occurs via divergent NF-kappaB activation. JPEN J Parenter Enteral Nutr 2004; 28:232-239, discussion 239-240.
26. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005;67:867-874. (Pubitemid 41623311)
27. Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharidestimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 2003;34:1006-1016. (Pubitemid 36398560)
28. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 2007;18:250-258. (Pubitemid 46389578)
29. Spears M, McSharry C, Thomson NC. Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 2006;36:1494-1504. (Pubitemid 44902926)
30. Becker J, Delayre-Orthez C, Frossard N, Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fundam Clin Pharmacol 2006;20:429-447. (Pubitemid 44393958)
31. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990-994. (Pubitemid 27485693)
32. Sakai H, Chiba Y, Hirano T, Misawa M. Possible involvement of CPI- 17 in augmented bronchial smooth muscle contraction in antigeninduced airway hyper-responsive rats. Mol Pharmacol 2005;68: 145-151. (Pubitemid 41002953)
33. 2+ sensitization of myosin light chain20 phosphorylation. Mol Pharmacol 2003;63:714-721.
34. 2+ sensitivity of smooth muscle and non muscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325-1358.
35. Sakai H, Otogoto S, Chiba Y, Abe K, Misawa M. TNF-alpha augments the expression of RhoA in the rat bronchus. J Smooth Muscle Res 2004;40:25-34. (Pubitemid 39099394)
36. Sakai H, Otogoto S, Chiba Y, Abe K, Misawa M. Involvement of p42/44 MAPK and RhoA protein in augmentation of ACh-induced bronchial smooth muscle contraction by TNF-alpha in rats. J Appl Physiol 2004;97:2154-2159. (Pubitemid 39555539)
37. Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol 2009;158:960-971.
38. Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S, Israel E, Haley KJ, Serhan CN. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 2007;178:496-502. (Pubitemid 46039663)
39. Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M. Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 2008;367:509-515.
40. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004;350:560-569. (Pubitemid 38160786)
41. Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004;350:560-569. (Pubitemid 38160786)
42. Schwartz J, Weiss ST. The relationship of dietary fish intake to level of pulmonary function in the first National Health and Nutrition Survey (NHANES I). Eur Respir J 1994;7:1821-1824. (Pubitemid 24337354)
43. Peat JK, Mihrshahi S, Kemp AS, Marks GB, Tovey ER, Webb K, Mellis CM, Leeder SR. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 2004;114:807-813. (Pubitemid 39330250)
44. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 2002;8:1018-1023. (Pubitemid 35033707)